Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

2.3K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.3K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

843
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
843
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

1.3K
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
1.3K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

641
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
641
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings from the 17th Annual University of Calgary Leaders in Medicine Research Symposium.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same author

The co-existence of Ehlers-Danlos syndrome and postural orthostatic tachycardia syndrome: A systematic review of the literature.

Autonomic neuroscience : basic & clinical·2026
Same author

Gravitational load, sex, and age-sex effects on cardiovascular compensatory responses during sit-to-stand and lie-to-stand transitions.

American journal of physiology. Regulatory, integrative and comparative physiology·2026
Same author

Orthostatic hypotension: new frontiers in pharmacotherapeutic management.

Expert opinion on pharmacotherapy·2026
Same author

What are we treating? The need for broader provider understanding of POTS, its nature, and care.

The American journal of medicine·2026
Same author

Layer-specific choroidal vascular adaptation to high-altitude hypoxia revealed by functional OCT at 3,800 m.

Function (Oxford, England)·2026

Related Experiment Video

Updated: Feb 21, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

22.0K

Orthostatic hypotension for the cardiologist.

Philip L Mar1, Satish R Raj2,3

  • 1Krannert Institute of Cardiology, Indiana University, Indianapolis, Indiana, USA.

Current Opinion in Cardiology
|October 7, 2017
PubMed
Summary

Orthostatic hypotension management is evolving, with new guidelines and FDA-approved treatments like droxidopa. Cardiologists are key to improving patient quality of life and reducing cardiovascular risk in this condition.

More Related Videos

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

1.4K
Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.1K

Related Experiment Videos

Last Updated: Feb 21, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

22.0K
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

1.4K
Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.1K

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Orthostatic hypotension (OH) is a common clinical finding with significant prognostic implications.
  • Increasing evidence links OH to cardiovascular morbidity and mortality.
  • Cardiologists are increasingly involved in managing patients with OH.

Purpose of the Study:

  • To review recent advances in the diagnosis, treatment, and management of orthostatic hypotension.
  • To highlight the evolving role of cardiologists in OH patient care.
  • To discuss new therapeutic options and guidelines.

Main Methods:

  • Review of recent consensus guidelines from major cardiology societies.
  • Analysis of FDA approvals for OH treatments.
  • Synthesis of findings from recent clinical studies on pharmacologic and non-pharmacologic interventions.
  • Evaluation of novel screening tools for OH.

Main Results:

  • Updated consensus guidelines reinforce the definition and management of OH.
  • Droxidopa, approved in 2014, is an effective treatment for neurogenic orthostatic hypotension (nOH).
  • Midodrine, approved in 1986, remains a key pharmacologic agent.
  • Studies compare pharmacologic agents and non-pharmacologic interventions.
  • Newer, convenient screening tools for OH are emerging.

Conclusions:

  • Despite advances, nOH remains a chronic and progressive condition.
  • Cardiologists play a crucial role in optimizing hemodynamics for OH patients.
  • Improved management can enhance quality of life and minimize cardiovascular risk.